Author Instructions
Submitting Manuscripts to Insulin
The Editors of Insulin welcome manuscript submissions—including clinical research reports, review articles, and case reports—that adhere to the guidelines set forth below:
Authorship
Insulin considers manuscripts that conform to the established guidelines of the International Committee of Medical Journal Editors (ICMJE), as described in “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication – Updated October 2004.” These guidelines are available at www.icmje.org (also published in N Engl J Med. 1997;336:309–315).
As stated in the ICMJE Uniform Requirements, credit for authorship requires substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafting of the manuscript or critical revision for important intellectual content; and final approval of the
version to be published.
At the time of submission, Insulin requires the author of an article to sign a statement that he or she has approved the search terms, article selection, and manuscript outline, and accepts full responsibility for all conclusions drawn. Any change in authorship after submission must be approved in writing by all authors.
Copyright Ownership
Each author is required to sign a form for the transfer of copyright ownership before the publication of an accepted manuscript. This form acknowledges transfer of copyright and all worldwide rights, title, and interest of the manuscript to Excerpta Medica Inc., an Elsevier business.
Manuscript Components
All manuscripts should be in English, typed, and double-spaced, with the pages numbered. The title page of the paper should include a concise title of the article; the full name(s) of the author(s), highest academic degree(s) (eg, MD), and professional affiliation; and complete contact information—including mailing address, telephone, fax, and e-mail address of the corresponding author.
Any drugs that are mentioned in the manuscript should be referred to by their universally accepted generic names, not by company trademarks. US adopted names (USANs) are acceptable. Footnotes and uncommon abbreviations should be avoided whenever possible. When abbreviations or symbols are used, they should be defined in the text the first time they appear; any tables and figures shouldn be referred to in the text. Graphics that have been published elsewhere must be accompanied by written consent from the original author and publisher for print and electronic reproduction.
Review Articles
Unsolicited review articles and meta-analyses of the literature on topics relating to insulin use in people with diabetes are welcomed.
A review article should include a concise title; a structured abstract (a brief description that provides the context or background for the study and states the study's purpose(s), methods, findings, and conclusions, emphasizing new and important aspects of the study or observations); ~5 key clinical points for presentation in call-out boxes within the article; an introduction that specifies the purpose of the review; a section on methods that identifies the databases that were searched, key words or phrases used, and inclusion/exclusion criteria for identified articles; an assessment of the validity of reviewed studies; and a summary that includes future directions for studies in this area.
Abstract length: ≤300 words
Article length: ≤3500 words
References: ≤50
Graphics: ≤5 tables, figures, or illustrations
Clinical Research Reports
Original reports of practical clinical studies relevant to the use of insulin in patients with diabetes are also considered.
A clinical research report should include a concise title; a structured abstract (a brief description that provides the context or background for the study and states the study's purpose(s), methods, findings, and conclusions, emphasizing new and important aspects of the study or observations); an introduction that specifies the purpose of the study; a section on methods that describes the protocol for the study (including the selection and description of study subjects, technical information, and statistical methods); a section on the results of the study; and discussion and conclusions of the study. References for all statements relating to the research of others should be provided, using the original sources whenever possible.
Case Reports/Studies
Case reports describe observations of new or unusual events (eg, relating to a clinical condition, association, reaction, or treatment) in one or more patients that can advance basic understanding of a medical condition, increase clinical skills, or suggest the usefulness of further research. The report should be factual, concise, logically organized, and clearly presented. Consistent with ICMJE guidelines, no identifying information—including patients' names, initials, or healthcare facility identification numbers—should be published in case studies to protect patient privacy and confidentiality. (Note: Please do not submit cases purporting to establish drug efficacy.)
The case report should include a concise title, an introduction, a description of the case, discussion, a summary, and any relevant references. A table or figure that presents data in a readily interpretable form may be included. The introduction should announce the subject and purpose of the report, including statements of why the case is important. The case description should include a narrative account of the case with pertinent clinical, laboratory, and medication information. Discussion may include evidence that the case is new or unusual and consider possible alternative explanations for case features. The summary may include questions for further consideration, request for input from other experts in the field, and preliminary conclusions of the author.
Insulin features an interactive forum to discuss the content of case reports. To facilitate this exchange of ideas, readers are invited to submit comments about each case report to the Insulin Web site via www.insulinjournal.com/caserespond.php. Comments from readers may be posted on this Web site, along with their names, credentials, and professional affiliations when permission is granted. A summary of reader comments that are received by each published deadline will appear in the next issue of Insulin. (Note: Reader comments may be edited for length, grammatical correctness, and journal style.)
Report length: ≤500 words
References: ≤10
Graphic: 1 table, figure, or illustration
References
The accuracy of all references cited is the responsibility of the author. References should be numbered in the order in which they appear in the text and the full references listed in the corresponding order at the end of the manuscript. The listing of references should comply with the format set forth in the American Medical Association Manual of Style: A Guide for Authors and Editors. 9th ed. Chicago, Ill: American Medical Association; 1998 (see following samples for journal articles, books, and Web sites). Data on file and material that has been "submitted for publication" should not be included in the references.
Journal Article
Reference to a journal article should include the last names and initials of the authors; full title of the article; full title of the journal, italicized; year of publication; volume number; and inclusive pages of the article. For example,
Pereira MA, Kartashov AI, Ebbeling CB, et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet. 2005;365:36-42.
Book
Reference to a book should include the last names and initials of the authors and/or editors; chapter title; book title, italicized; edition number; place of publication; publisher; year of publication; and inclusive pages. For example,
Anderson RM, Funnel MM, Carlson A, et al. Facilitating self-care through empowerment. In: Snoek FJ, Skinner TC, eds. Psychology in Diabetes Care. West Essex, UK: John Wiley & Sons, Ltd; 2000:69-97.
Web site
Reference to a Web site should include its name, article title, Web site address, and date the Web site was accessed. For example,
World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects. http://www.wma.net/e/policy/pdf/17c.pdf. Accessed July 1, 2005.
Tables
Each table should be prepared in Microsoft Word and inserted after the references. Each table should:
- be referred to in the text;
- be numbered in the order of appearance;
- include a short, descriptive title; and
- be printed on a separate page.
Figures
Figures should be created in Adobe Illustrator and submitted on disk or electronically (.pdf or .eps format); photographs and photocopies are not usable. Figures submitted in any other format may be redrawn and forwarded for review to authors, who will be responsible for the accuracy of the new illustrations. Use arrows indicating the top of the figures where needed. Each figure should be:
- referred to in the text;
- numbered in the order of appearance; and
- printed on a separate page.
A numbered list of short, descriptive figure legends should be included at the end of the paper.
Acknowledgments
Financial Disclosure
Authors are required to disclose, in writing, any financial interests (eg, employment, consultancies, stock ownership or options other than mutual funds, honoraria, expert testimony) in the materials or subject matter dealt with in the manuscript.
Manuscript Preparation
Any contributions to the research or assistance in manuscript preparation by any person(s) other than the authors must be acknowledged.
File Formats
Both mail and electronic submissions should adhere to the following file formats:
Cover letter, manuscript, and tables—Microsoft Word (.doc)
Figures—Adobe PDF (.pdf) or Adobe Illustrator (.eps)
Submit Manuscripts to:
Steven V. Edelman, MD, and Derek LeRoith, MD, PhD, Insulin, Excerpta Medica, 685 Route 202/206, Bridgewater, NJ 08807 or insulin@elsevier.com.
|
